Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/1999
12/02/1999CA2333320A1 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329076A1 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2328905A1 Prostate growth-associated membrane proteins
12/01/1999EP0960621A2 Pharmaceutical formulations comprising sildenafil
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0655056B1 Azacyclyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
12/01/1999CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives
12/01/1999CN1236643A Medicine for curing impotence
12/01/1999CN1046942C Imidazopyridines
11/1999
11/30/1999US5994616 Targeted synthesis of protein in mammary gland of a non-human transgenic mammal
11/30/1999US5994547 Process for preparing benzo[b]thiophenes
11/30/1999US5994537 Process for preparing azepinone compounds useful in the inhibition of ACE and NEP
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994369 Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/30/1999US5994363 Amelioration of apomorphine adverse effects
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994294 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
11/30/1999US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5993856 Pharmaceutical preparations and methods for their administration
11/30/1999US5993810 Method of softening or ripening the cervix of a female mammal using collagenase
11/25/1999WO1999059969A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999WO1999059581A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999WO1999059575A1 Compositions comprising organic mono- or dinitrate for treating impotence
11/25/1999WO1999059525A2 Broad spectrum microbicidal and spermicidal compositions, devices, and methods
11/25/1999CA2332328A1 Compositions comprising organic mono- or dinitrate for treating impotence
11/25/1999CA2331318A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999CA2329530A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/24/1999EP0957910A2 Method of regulating the female reproductive system through angiogenesis inhibitors
11/24/1999EP0550703B1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs
11/24/1999CN1235827A Estradiol benzoate gel agent and its preparing method
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/23/1999US5990129 Regulation of trka, the receptor for the neurotrophin nerve growth factor (ngf), by the administration of 2-aryl-3-aroylbenzo(b)thiophenes of given formula
11/23/1999US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989581 Thermoplastic polymer core and skin containing steroidal progestogenic compound and steroidal estrogenic compound
11/23/1999US5989550 Materials and methods for immunocontraception
11/23/1999US5989549 Acrosomal sperm protein and uses thereof
11/23/1999CA2207694C Process for preparing sildenafil
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058533A1 Phenylurea and phenylthio urea derivatives
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058110A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999WO1999047642A9 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999CA2331962A1 Meiosis regulating compounds
11/18/1999CA2331735A1 Phenylurea and phenylthio urea derivatives
11/18/1999CA2331350A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0956858A1 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999EP0956024A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
11/17/1999EP0956022A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
11/17/1999CN1235556A Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985889 Dosage forms and method for ameliorating male erectile dysfunction
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/15/1999CA2272042A1 Pharmaceutical formulations of sildenafil
11/11/1999WO1999057293A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999056741A1 Methods for treating female sexual dysfunction
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999056666A1 The treatment of sexual dysfunction in certain patient groups
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2328132A1 Growth-associated protease inhibitor heavy chain precursor
11/11/1999CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999CA2327355A1 Human receptor molecules
11/11/1999CA2326957A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/10/1999EP0955294A2 Imidazolyl-alkenoic acid
11/10/1999EP0954578A1 Glycoprotein hormone superagonists
11/10/1999EP0954314A1 Dosage forms and method for ameliorating male erectile dysfunction
11/10/1999EP0954307A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
11/10/1999EP0954298A1 Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale
11/10/1999CN1234267A Anrutong capsule for treatment of mammary-gland disease
11/09/1999US5981563 Orally administering a rapidly dissolving tablet comprising phentolamine or its pharmaceutically acceptable salts
11/09/1999US5981527 Cyclic GMP-specific phosphodiesterase inhibitors
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981470 Administering pharmaceutical agent selected from the group consisting of an angiotensin converting enzyme inhibitor, an angiotensin ii-receptor antagonist, a renin inhibitor, and an angiotensin ii-receptor expression inhibitor
11/09/1999US5981228 Mammalian ZPAs
11/09/1999US5981222 Mammalian polynucleotide encoding protein factor; for disease prevention and treatment
11/09/1999US5980940 Pharmaceutical combination preparation for hormonal contraception